Meanwhile, EPO has been used successfully in a couple of diseases, treating anaemia in AIDS[13], in renal failure[14], as well as for limiting brain damage in experimental auto-immune encephalomyelitis[15], and also been proposed for treatment of haemoglobinopathies in which β-globin synthesis is affected[16,17]. The gene discussed is EPO; the disease is anemia.